|
Lucas-Ruiz F, Penin-Franch A, Pons JA, Ramirez P, Pelegrin P, Cuevas S, Baroja-Mazo A. Emerging Role of NLRP3 Inflammasome and Pyroptosis in Liver Transplantation. Int J Mol Sci. 2022 Nov 19;23(22):14396. doi: 10.3390/ijms232214396. PubMed PMID: 36430874; PubMed Central PMCID: PMC9698208.
AÑO: 2022; IF: 5.6
|
36430874
|
Hurtado-Navarro L, Baroja-Mazo A, Pelegrin P. Characterization of P2X7 Receptors in Human Blood Cells. Methods Mol Biol. 2022;2510:279-290. doi: 10.1007/978-1-0716-2384-8_15. PubMed PMID: 35776331.
AÑO: 2022
|
|
Pizzuto M, Pelegrin P, Ruysschaert JM. Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome. Prog Lipid Res. 2022 Jul;87:101182. doi: 10.1016/j.plipres.2022.101182. Epub 2022 Jul 25. PubMed PMID: 35901922; PubMed Central PMCID: PMC7613582.
AÑO: 2022; IF: 13.6
|
|
Hurtado-Navarro L, Angosto-Bazarra D, Pelegrin P, Baroja-Mazo A, Cuevas S. NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers. Antioxidants (Basel). 2022 Apr 28;11(5):870. doi: 10.3390/antiox11050870. PubMed PMID: 35624734; PubMed Central PMCID: PMC9137763.
AÑO: 2022; IF: 7.675
|
|
Penin-Franch A, Garcia-Vidal JA, Martinez CM, Escolar-Reina P, Martinez-Ojeda RM, Gomez AI, Bueno JM, Minaya-Munoz F, Valera-Garrido F, Medina-Mirapeix F, Pelegrin P. Galvanic current activates the NLRP3 inflammasome to promote Type I collagen production in tendon. Elife. 2022 Feb 24;11:e73675. doi: 10.7554/eLife.73675. PubMed PMID: 35199642; PubMed Central PMCID: PMC8896827.
AÑO: 2022; IF: 7.7
|